Proteome signatures of inflammatory activated primary human peripheral blood mononuclear cells

Journal of Proteomics

Volumn 76, Issue , 2012, Pages 150-162

  Haudek Prinz, Verena J ^a,b   Klepeisz, Philip ^b   Slany, Astrid ^a,b   Griss, Johannes ^b,c,d   Meshcheryakova, Anastasia ^b   Paulitschke, Verena ^d   Mitulovic, Goran ^e   Stöckl, Johannes ^f   Gerner, Christopher ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

^d Universitatsklinik fur Dermatologie   (Austria)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Clinical proteomics; Functional signature; Inflammation; Mass spectrometry; Proteome profiling; White blood cells

Indexed keywords

BINDING PROTEIN; GUANYLATE BINDING PROTEIN 5; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROGRAMMED CELL DEATH PROTEIN 5; PROGRAMMED DEATH 1 RECEPTOR; PROTEOME; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL ACTIVATION; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; LIQUID CHROMATOGRAPHY; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEOMICS; T LYMPHOCYTE; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL POLYACRYLAMIDE GEL ELECTROPHORESIS;

BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; MALE; MASS SPECTROMETRY; PROTEOME; PROTEOMICS; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 84869866569     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.07.012     Document Type: Article

References (60)

1. Desiere F, Deutsch EW, Nesvizhskii AI, Mallick P, King NL, Eng JK, et al. Integration with the human genome of peptide sequences obtained by high-throughput mass spectrometry. Genome Biol 2005, 6:R9.
2. Vergara D, Chiriaco F, Acierno R, Maffia M Proteomic map of peripheral blood mononuclear cells. Proteomics 2008, 8:2045-2051.
3. Haudek VJ, Slany A, Gundacker NC, Wimmer H, Drach J, Gerner C Proteome maps of the main human peripheral blood constituents. J Proteome Res 2009, 8:3834-3843.
4. Wimmer H, Gundacker NC, Griss J, Haudek VJ, Stattner S, Mohr T, et al. Introducing the CPL/MUW proteome database: interpretation of human liver and liver cancer proteome profiles by referring to isolated primary cells. Electrophoresis 2009, 30:2076-2089.
5. de Roos B, Duthie SJ, Polley AC, Mulholland F, Bouwman FG, Heim C, et al. Proteomic methodological recommendations for studies involving human plasma, platelets, and peripheral blood mononuclear cells. J Proteome Res 2008, 7:2280-2290.
6. Mills KH TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol 2011, 11:807-822.
7. Monaco C, Andreakos E, Kiriakidis S, Feldmann M, Paleolog E T-cell-mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseases. Curr Drug Targets Inflamm Allergy 2004, 3:35-42.
8. Hatsugai M, Kurokawa MS, Kouro T, Nagai K, Arito M, Masuko K, et al. Protein profiles of peripheral blood mononuclear cells are useful for differential diagnosis of ulcerative colitis and Crohn's disease. J Gastroenterol 2010, 45:488-500.
9. Wang L, Dai Y, Qi S, Sun B, Wen J, Zhang L, et al. Comparative proteome analysis of peripheral blood mononuclear cells in systemic lupus erythematosus with iTRAQ quantitative proteomics. Rheumatol Int 2012, 32:585-593.
10. Dotzlaw H, Schulz M, Eggert M, Neeck G A pattern of protein expression in peripheral blood mononuclear cells distinguishes rheumatoid arthritis patients from healthy individuals. Biochim Biophys Acta 2004, 1696:121-129.
11. Ingersoll MA, Platt AM, Potteaux S, Randolph GJ Monocyte trafficking in acute and chronic inflammation. Trends Immunol 2011, 32:470-477.
12. Tan TT, Coussens LM Humoral immunity, inflammation and cancer. Curr Opin Immunol 2007, 19:209-216.
13. Siegel D., Devaraj S., Mitra A., Raychaudhuri S.P., Raychaudhuri S.K., Jialal I Inflammation, atherosclerosis, and psoriasis. Clin Rev Allergy Immunol 2012, [Electronic publication ahead of print].
14. Holmes C, Butchart J Systemic inflammation and Alzheimer's disease. Biochem Soc Trans 2011, 39:898-901.
15. Thomas S, Bonchev D A survey of current software for network analysis in molecular biology. Hum Genomics 2010, 4:353-360.
16. Gundacker NC, Haudek VJ, Wimmer H, Slany A, Griss J, Bochkov V, et al. Cytoplasmic proteome and secretome profiles of differently stimulated human dendritic cells. J Proteome Res 2009, 8:2799-2811.
17. Haudek VJ, Gundacker NC, Slany A, Wimmer H, Bayer E, Pable K, et al. Consequences of acute and chronic oxidative stress upon the expression pattern of proteins in peripheral blood mononuclear cells. J Proteome Res 2008, 7:5138-5147.
18. Hoelzl C, Lorenz O, Haudek V, Gundacker N, Knasmuller S, Gerner C. Proteome alterations induced in human white blood cells by consumption of Brussels sprouts: results of a pilot intervention study. Proteomics Clin Appl 2008, 2:108-117.
19. Smith M.P., Wood S.L., Zougman A., Ho J.T., Peng J., Jackson D., et al. A systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analyses. Proteomics 2011, 11:2222-2235.
20. Griss J., Haudek-Prinz V., Gerner C. GPDE: a biological proteomic database for biomarker discovery and evaluation. Proteomics 2011, 11:1000-1004.
21. Gerner C., Sauermann G. Nuclear matrix proteins specific for subtypes of human hematopoietic cells. J Cell Biochem 1999, 72:470-482.
22. Traxler E., Bayer E., Stockl J., Mohr T., Lenz C., Gerner C. Towards a standardized human proteome database: quantitative proteome profiling of living cells. Proteomics 2004, 4:1314-1323.
23. Pickl W.F., Majdic O., Kohl P., Stockl J., Riedl E., Scheinecker C., et al. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J Immunol 1996, 157:3850-3859.
24. Gerner C., Vejda S., Gelbmann D., Bayer E., Gotzmann J., Schulte-Hermann R., et al. Concomitant determination of absolute values of cellular protein amounts, synthesis rates, and turnover rates by quantitative proteome profiling. Mol Cell Proteomics 2002, 1:528-537.
25. Kirchberger S., Majdic O., Steinberger P., Bluml S., Pfistershammer K., Zlabinger G., et al. Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression. J Immunol 2005, 175:1145-1152.
26. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu Rev Immunol 2003, 21:335-376.
27. Janeway C.A., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002, 20:197-216.
28. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001, 13:85-94.
29. Waclavicek M., Majdic O., Stulnig T., Berger M., Sunder-Plassmann R., Zlabinger G.J., et al. CD99 engagement on human peripheral blood T cells results in TCR/CD3-dependent cellular activation and allows for Th1-restricted cytokine production. J Immunol 1998, 161:4671-4678.
30. Ceuppens J.L., Baroja M.L., Lorre K., Van Damme J., Billiau A. Human T cell activation with phytohemagglutinin. The function of IL-6 as an accessory signal. J Immunol 1988, 141:3868-3874.
31. De Groote D., Zangerle P.F., Gevaert Y., Fassotte M.F., Beguin Y., Noizat-Pirenne F., et al. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992, 4:239-248.
32. Chen X., Vodanovic-Jankovic S., Johnson B., Keller M., Komorowski R., Drobyski W.R. Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease. Blood 2007, 110:3804-3813.
33. Zeng G., Chen J., Liang Q.H., You W.H., Wu H.J., Xiong X.G. Ursolic acid inhibits T-cell activation through modulating nuclear factor-kappa B signaling. Chin J Integr Med 2012, 18:34-39.
34. Van Seventer G.A., Shimizu Y., Horgan K.J., Shaw S. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol 1990, 144:4579-4586.
35. Gundacker N., Bayer E., Traxler E., Zwickl H., Kubicek M., Stockl J., et al. Knowledge-based proteome profiling: considering identified proteins to evaluate separation efficiency by 2-D PAGE. Electrophoresis 2006, 27:2712-2721.
36. Rabilloud T., Strub J.M., Luche S., van Dorsselaer A., Lunardi J. A comparison between Sypro Ruby and ruthenium II tris (bathophenanthroline disulfonate) as fluorescent stains for protein detection in gels. Proteomics 2001, 1:699-704.
37. Zwickl H., Traxler E., Staettner S., Parzefall W., Grasl-Kraupp B., Karner J., et al. A novel technique to specifically analyze the secretome of cells and tissues. Electrophoresis 2005, 26:2779-2785.
38. Mortz E., Krogh T.N., Vorum H., Gorg A. Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics 2001, 1:1359-1363.
39. Slany A., Haudek V.J., Gundacker N.C., Griss J., Mohr T., Wimmer H., et al. Introducing a new parameter for quality control of proteome profiles: consideration of commonly expressed proteins. Electrophoresis 2009, 30:1306-1328.
40. Nesvizhskii A.I., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003, 75:4646-4658.
41. Ishihama Y., Oda Y., Tabata T., Sato T., Nagasu T., Rappsilber J., et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 2005, 4:1265-1272.
42. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000, 25:25-29.
43. Hwu P., Du M.X., Lapointe R., Do M., Taylor M.W., Young H.A. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 2000, 164:3596-3599.
44. Munn D.H., Shafizadeh E., Attwood J.T., Bondarev I., Pashine A., Mellor A.L. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 1999, 189:1363-1372.
45. Essers J., Theil A.F., Baldeyron C., van Cappellen W.A., Houtsmuller A.B., Kanaar R., et al. Nuclear dynamics of PCNA in DNA replication and repair. Mol Cell Biol 2005, 25:9350-9359.
46. Zhang H., Zhao C., Li X., Zhu Y., Gan C.S., Wang Y., et al. Study of monocyte membrane proteome perturbation during lipopolysaccharide-induced tolerance using iTRAQ-based quantitative proteomic approach. Proteomics 2010, 10:2780-2789.
47. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
48. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 1993, 90:7915-7922.
49. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
50. Silva E., O'Gorman M., Becker S., Auer G., Eklund A., Grunewald J., et al. In the eye of the beholder: does the master see the SameSpots as the novice?. J Proteome Res 2010, 9:1522-1532.
51. Cantor J.M., Ginsberg M.H., Rose D.M. Integrin-associated proteins as potential therapeutic targets. Immunol Rev 2008, 223:236-251.
52. Kurki P., Lotz M., Ogata K., Tan E.M. Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes. J Immunol 1987, 138:4114-4120.
53. Liu H., Wang Y., Zhang Y., Song Q., Di C., Chen G., et al. TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun 1999, 254:203-210.
54. Tian M., Xiaoyi W., Xiaotao L., Guosheng R. Proteasomes reactivator REG gamma enchances oncogenicity of MDA-MB-231 cell line via promoting cell proliferation and inhibiting apoptosis. Cell Mol Biol (Noisy-le-Grand) 2009, 55(Suppl.:OL1121-31).
55. Lanoix J., Lacoste J., Pepin N., Rice N., Hiscott J. Overproduction of NFKB2 (lyt-10) and c-Rel: a mechanism for HTLV-I tax-mediated trans-activation via the NF-kappa B signalling pathway. Oncogene 1994, 9:841-852.
56. Kanno Y., Levi B.Z., Tamura T., Ozato K. Immune cell-specific amplification of interferon signaling by the IRF-4/8-PU.1 complex. J Interferon Cytokine Res 2005, 25:770-779.
57. Vestal D.J., Jeyaratnam J.A. The guanylate-binding proteins: emerging insights into the biochemical properties and functions of this family of large interferon-induced guanosine triphosphatase. J Interferon Cytokine Res 2011, 31:89-97.
58. Bange F.C., Vogel U., Flohr T., Kiekenbeck M., Denecke B., Bottger E.C. IFP 35 is an interferon-induced leucine zipper protein that undergoes interferon-regulated cellular redistribution. J Biol Chem 1994, 269:1091-1098.
59. Haller O., Kochs G. Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J Interferon Cytokine Res 2011, 31:79-87.
60. Sotzik F., Boyd A., Shortman K. Surface antigens of human thymocyte populations defined by CD3, CD4 and CD8 expression: CD1a is expressed by mature thymocytes but not peripheral T cells. Immunol Lett 1993, 36:101-106.